Immune (dys)regulation in multiple sclerosis: role of the CD95–CD95 ligand system
- 1 December 1999
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 20 (12) , 550-554
- https://doi.org/10.1016/s0167-5699(99)01545-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Impairment of TNF-Receptor-1 Signaling but not Fas Signaling Diminishes T-Cell Apoptosis in Myelin Oligodendrocyte Glycoprotein Peptide-Induced Chronic Demyelinating Autoimmune Encephalomyelitis in MiceThe American Journal of Pathology, 1999
- T-Cell Apoptosis in Inflammatory Brain Lesions: Destruction of T Cells Does Not Depend on Antigen RecognitionThe American Journal of Pathology, 1998
- A potential role for FAS (CP95/APO-1) int he recovery phase of experimental autoimmune encephalomyelitisJournal of Neuroimmunology, 1998
- RETRACTED: The Fas/Fas Ligand Pathway and Bcl-2 Regulate T Cell Responses to Model Self and Foreign AntigensImmunity, 1998
- Multiple sclerosis: Oligodendrocytes display cell death–related molecules in situ but do not undergo apoptosisAnnals of Neurology, 1997
- Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell DeathThe Journal of Experimental Medicine, 1996
- Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain.The Journal of Experimental Medicine, 1996
- Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)Nature, 1995
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- T Cell Deletion in High Antigen Dose Therapy of Autoimmune EncephalomyelitisScience, 1994